These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 8793610)

  • 1. Drug attitude and adherence to anti-glaucoma medication.
    Hong S; Kang SY; Yoon JU; Kang U; Seong GJ; Kim CY
    Yonsei Med J; 2010 Mar; 51(2):261-9. PubMed ID: 20191020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of serum magnesium determination in hypertensive patients receiving diuretics.
    Kroenke K; Wood DR; Hanley JF
    Arch Intern Med; 1987 Sep; 147(9):1553-6. PubMed ID: 3632162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension.
    Bénétos A; Laflèche A; Asmar R; Gautier S; Safar A; Safar ME
    J Hum Hypertens; 1996 Feb; 10(2):77-82. PubMed ID: 8867559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
    MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344757
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlations between subjective compliance, objective compliance, and factors determining compliance in geriatric hypertensive patients treated with triamterene and hydrochlorothiazide.
    Oelzner S; Brandstädt A; Hoffmann A
    Int J Clin Pharmacol Ther; 1996 Jun; 34(6):236-42. PubMed ID: 8793610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Properties and indications of potassium-sparing diuretics].
    Rorive G; Krzesinski JM
    Rev Med Liege; 1986 May; 41(9):330-6. PubMed ID: 3523669
    [No Abstract]   [Full Text] [Related]  

  • 8. Chirally pure S-metoprolol--place in therapy.
    Dasbiswas A; Dasbiswas D
    Indian Heart J; 2010; 62(2):143-5. PubMed ID: 21180306
    [No Abstract]   [Full Text] [Related]  

  • 9. Compliance: the case for objective measurement.
    Caron HS
    J Hypertens Suppl; 1985 Apr; 3(1):S11-7. PubMed ID: 3916439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social support and compliance: update.
    Levy RL
    J Hypertens Suppl; 1985 Apr; 3(1):S45-9. PubMed ID: 3916442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of quality of life in hypertension therapy: implication for patient compliance.
    Turner RR
    Cardiology; 1992; 80 Suppl 1():11-22. PubMed ID: 1600535
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.